Med tech programme at Genesis 2009 biotechnology conference

27 October 2009

Genesis 2009, the UK's leading biotechnology networking conference will be held on 10-11 December 2009 at the QEII conference centre in London.

This year the organisers have given a significant focus to the development and commercial aspects of medical technology as well as biotechnology.

To this end there is a dedicated medical technology stream at Genesis on Day 2 and this is complemented by presentations on Day 1, including showcasing of imaging technologies, the Massachusetts Med Tech story, a VC view and others.

The MedTech session includes:

  • The structure of the medical technology sector in the UK, Barnaby Perks, ERBI
  • Evaluating the market potential of your product, MATCH Speaker tbc
  • Developing the value proposition for investors, Stuart Hendry, Sphere Medical
  • Comparing the FDA and EMEA approaches to approval for biomarkers, Patricia Hurley, Head of Biomarkers Division, ERA Consulting
  • Undertaking med tech clinical trials in the NHS, Prof. Gordon Ferns, Dean of Medicine, University of Surrey
  • Preparing to market your product, Bill Dolphin, Avita Medical
  • Building revenues through entering the US market, Ted Agne, Communications Strategy Group
  • Keynote debate: The OLS Blueprint has the NHS as an Innovation Champion, but how can you get your innovative med tech product adopted by the NHS? Chair: Bill Dawson; Panellists: Prof Gordon Ferns, University of Surrey; Mark McIntyre, Boston Scientific; Others to be confirmed.

For more information see:


To top